Clinical Trials Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Mar 7, 2016; 22(9): 2837-2843
Published online Mar 7, 2016. doi: 10.3748/wjg.v22.i9.2837
Table 5 Survival time vs combined α-fetoprotein level and SALL4 expression in postoperative hepatocellular carcinoma patients
GroupCasesMedian survival time(mo)P value
AFP (-)/SALL4 (-)941
AFP (-)/SALL4 (+)738
AFP (+)/SALL4 (-)5931
AFP (+)/SALL4 (+)51120.000